頁籤選單縮合
題 名 | 中臺灣區域教學醫院2020年使用不同新冠檢測平臺的經驗=Experience of Differential COVID-19 Diagnostic Methods in a Metropolitan Hospital in Central Taiwan |
---|---|
作 者 | 童耀申; 郭丁吉; 江沛錡; 吳靜怡; 楊玉英; 楊佩玉; 施珮筑; | 書刊名 | 秀傳醫學雜誌 |
卷 期 | 22:3 2023.12[民112.12] |
頁 次 | 頁326-332 |
分類號 | 415.23 |
關鍵詞 | 新型冠狀病毒; 指定檢驗機構檢驗方法; 瑞基新型冠狀病毒檢測; COVID-19; Laboratory-developed assay; LDT; POCKIT; ii RT-PCR; |
語 文 | 中文(Chinese) |
DOI | 10.30185/SCMJ.202312_22(3).0003 |
中文摘要 | 根據WHO的最新統計數據,從2019年12月直至2021年8月中,全球多達2.16億人被診斷出新冠病毒(COVID-19),導致近450萬人死亡。COVID-19檢驗是防疫最重要的一個關卡。本研究使用之檢體為公費或自費檢驗COVID-19需求者。檢驗方法:1.指定檢驗機構檢驗方法(LDT)、2.瑞基新型冠狀病毒檢測。秀傳紀念醫院從2020年4月29日開始提供體系三院區COVID-19檢測服務,至2020年底,共執行3,381件的檢測。秀傳公費送驗檢體共1,793件,男性占比65.81%、女性占34.19%;本國籍佔62.41%、外國籍佔37.59%;主要送驗單位為急診及感染科。自費檢驗共1,147件,男性占72.10%、女性占27.90%;年齡主要分布在20-50歲的勞動年齡,自費受檢因素大多為工作需求。我們使用兩種檢測平台,其中以LDT方式的有2,325件,瑞基有1,056件;LDT有疑似無法判定的發生機率為1.8%;瑞基檢測無法判定的發生率為1.0%。目前因應COVID-19的篩選平台已經越來越多,每個平台各有其優缺點及適合的時機;LDT適合確診案例或檢體量多;而瑞基適合急件時篩檢。本研究統計2020年成立至年底兩個平台的使用經驗,供其他單位參考。 |
英文摘要 | Globally, the World Health Organization (WHO) has reported 216 million confirmed cases of COVID-19, including 4.5 million deaths. Diagnosis of COVID-19 is the most effective method of preventing the epidemic. This study tests clinical samples for COVID-19 at Show Chwan Memorial Hospital from April 29, 2020 to December 31, 2020. Two detection platforms were used: LDT and POCKIT (ii RT-PCR). A total of 3,381 COVID-19 diagnostic tests were performed, of which 1,793 diagnostic tests were used to diagnose notifiable infectious diseases. Of the 3,381 tests, 72.1% were conducted on men and 27.9% on women, and 65.8% were performed on Taiwanese subjects and 34.2% on foreign subjects. Most of the patients came from the emergency and infection departments. A total of 1,147 self-financed screenings were conducted, of which 72.1% were conducted on men and 27.9% on women. Most of the people who were tested were of working age (20 - 50 years) and most tests were conducted because of employment requirements. Of the 3,381 tests, 2,325 were conducted using LDT and 1,056 using POCKIT (ii RT-PCR). The rate of indeterminate results for LDT and POCKIT (ii RT-PCR) were 1.8% and 1.0%, respectively. This study shows that each of the increasing number of screening platforms for COVID-19 has advantages and disadvantages. LDT is suitable for confirmed cases or large numbers of examinations and POCKIT (ii RT-PCR) is suitable for screening urgent cases. The prices of instruments and reagents also determine the selection of the testing method. |
本系統中英文摘要資訊取自各篇刊載內容。